CKIP-1: A scaffold protein and potential therapeutic target integrating multiple signaling pathways and physiological functions

被引:90
作者
Nie, Jing [1 ]
Liu, Lin [2 ]
He, Fuchu [3 ]
Fu, Xiaobing [4 ]
Han, Weidong [1 ]
Zhang, Lingqiang [3 ,5 ]
机构
[1] Peoples Liberat Army Gen Hosp, Inst Basic Med Sci, Dept Mol Biol, Beijing 100853, Peoples R China
[2] Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing 100853, Peoples R China
[3] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing 100850, Peoples R China
[4] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Inst Burns, Key Lab Wound Healing & Cell Biol, Beijing 100037, Peoples R China
[5] Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Liaoning Provin, Peoples R China
关键词
CKIP-1; PH domain; Localization; Interacting protein; Bone formation; Osteoporosis; PLECKSTRIN HOMOLOGY DOMAIN; CASEIN KINASE-II; ACTIN-CAPPING PROTEIN; UBIQUITIN LIGASE SMURF1; CANCER STEM-CELLS; PLASMA-MEMBRANE; WW DOMAIN; CK2; BETA; DIFFERENTIATION;
D O I
10.1016/j.arr.2012.07.002
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
The PH domain-containing casein kinase 2 interacting protein-1 (CKIP-1, also known as PLEKHO1) acts as a scaffold protein mediating interactions with multiple proteins, including CK2 alpha, CP alpha, AP-1/c-Jun, Akt, ATM, IFP35/Nmi and Smurf1. CKIP-1 functions through different ways, such as plasma membrane recruitment, transcriptional activity modulation and posttranscriptional modification regulation. Moreover, the subcellular localization of CKIP-1 is determined by several key amino acids in a cell type dependent style, and the nucleus/plasma membrane shuttle of CKIP-1 is regulated by different cell stresses. As an adaptor protein, CKIP-1 is involved in various important signaling pathways, controlling cell growth, apoptosis, differentiation, cytoskeleton and bone formation. Strikingly, CKIP-1 has been recently demonstrated to be a promising target for treatment of osteoporosis in rat models. In addition, more evidences suggest that CKIP-1 might also function as a potential tumor suppressor. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 34 条
[1]
A Smad action turnover switch operated by WW domain readers of a phosphoserine code [J].
Aragon, Eric ;
Goerner, Nina ;
Zaromytidou, Alexia-Ileana ;
Xi, Qiaoran ;
Escobedo, Albert ;
Massague, Joan ;
Macias, Maria J. .
GENES & DEVELOPMENT, 2011, 25 (12) :1275-1288
[2]
RECOMBINANT HUMAN CASEIN KINASE-II - A STUDY WITH THE COMPLETE SET OF SUBUNITS (ALPHA,ALPHA' AND BETA), SITE-DIRECTED AUTOPHOSPHORYLATION MUTANTS AND A BICISTRONICALLY EXPRESSED HOLOENZYME [J].
BODENBACH, L ;
FAUSS, J ;
ROBITZKI, A ;
KREHAN, A ;
LORENZ, P ;
LOZEMAN, FJ ;
PYERIN, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 220 (01) :263-273
[3]
Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2 [J].
Bosc, DG ;
Graham, KC ;
Saulnier, RB ;
Zhang, CJ ;
Prober, D ;
Gietz, RD ;
Litchfield, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14295-14306
[4]
The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein [J].
Canton, DA ;
Olsten, MEK ;
Kim, K ;
Doherty-Kirby, A ;
Lajoie, G ;
Cooper, JA ;
Litchfield, DW .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (09) :3519-3534
[5]
The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein [J].
Canton, David A. ;
Olsten, Mary Ellen K. ;
Niederstrasser, Hanspeter ;
Cooper, John A. ;
Litchfield, David W. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (47) :36347-36359
[6]
New insights into mechanism and regulation of actin capping protein [J].
Cooper, John A. ;
Sept, David .
INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 267, 2008, 267 :183-+
[7]
DAYAMAKIN M, 1994, CANCER RES, V54, P2262
[8]
Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95
[9]
Exploiting the PI3K/AKT pathway for cancer drug discovery [J].
Hennessy, BT ;
Smith, DL ;
Ram, PT ;
Lu, YL ;
Mills, GB .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (12) :988-1004
[10]
Ibáñez E, 2012, CURR MED CHEM, V19, P3031